tradingkey.logo

Catalyst Pharmaceuticals Announces Settlement Of Firdapse® Patent Litigation With Lupin Pharmaceuticals

ReutersAug 26, 2025 11:18 PM

- Catalyst Pharmaceuticals Inc CPRX.O:

  • UPDATED- CATALYST PHARMACEUTICALS ANNOUNCES SETTLEMENT OF FIRDAPSE® (AMIFAMPRIDINE) PATENT LITIGATION WITH LUPIN PHARMACEUTICALS

  • CATALYST PHARMACEUTICALS INC - LUPIN TO DELAY GENERIC FIRDAPSE LAUNCH UNTIL FEB 25, 2035

  • CATALYST PHARMACEUTICALS INC - AND LUPIN TO TERMINATE PATENT LITIGATION BETWEEN CATALYST/SERB AND LUPIN

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI